Bank of Montreal’s Lisata Therapeutics LSTA Stock Holding History

Bank of Montreal’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-133	Closed	-$3K	–	4389
2021 Q1	$3K	Buy	+133	New	+$4.03K	﹤0.01%	4827

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's LSTA Position: Q2 2021 in Review

Bank of Montreal sold out of Lisata Therapeutics (LSTA) in Q2 2021, closing a stake of 133 shares — an estimated $3K sold.

Bank of Montreal first reported a position in LSTA in Q4 2014 and held it in 12 quarters. The position peaked at $3K in Q1 2021. 27 funds tracked by Wall St. Rank hold LSTA as of Q2 2021.

Bank of Montreal reported no remaining Lisata Therapeutics position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 133 Lisata Therapeutics shares in Q2 2021, an estimated $3K.
Bank of Montreal first reported a position in Lisata Therapeutics in Q4 2014 and held it in 12 quarters.
Bank of Montreal's Lisata Therapeutics position peaked at $3K in Q1 2021.
27 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.